Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Willa Rosenbloom v. David E I Pyott et al
Case Number:
8:10-cv-01352
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
- Ford & Diulio
- Gibson Dunn
- Haeggquist & Eck
- Hueston Hennigan
- Irell & Manella
- Mayer Brown
- Robbins Geller
- Robbins LLP
- Robbins Umeda
- Shuman Glenn
- Theodora Oringher
Companies
Sectors & Industries:
-
May 28, 2015
Allergan Shakes Shareholders' Off-Label Botox Case
A California federal judge Wednesday tossed a derivative shareholder suit accusing Allergan Inc.'s board members of improperly marketing the cosmetic drug Botox for off-label uses after a voluntary dismissal by the plaintiffs, who the pharmaceutical giant argued no longer had standing following an acquisition by Actavis PLC.
-
April 30, 2015
Allergan Asks Judge To Nix Off-Label Botox Suit
Allergan Inc. urged a California federal judge on Wednesday to toss a derivative shareholder suit accusing the pharmaceutical firm's board of improperly marketing the cosmetic drug Botox for off-label uses, saying plaintiffs lack standing to bring the case since they are no longer shareholders.